Evolution of third-trimester pregnancy terminations in France.


Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
May 2020
Historique:
received: 08 10 2019
revised: 28 02 2020
accepted: 05 03 2020
pubmed: 24 3 2020
medline: 3 2 2021
entrez: 24 3 2020
Statut: ppublish

Résumé

To study changes in the reasons for third-trimester termination of pregnancy (TOP) for fetal anomalies over a 20-year period in France. We compared a consecutive series of third-trimester TOPs from a single centre in 2005-2014 to those performed by Dommergues et al. in a similar centre in 1986-1994, using the same criteria. The process leading to late TOP, using the same categories in both studies. In the present series, 205 of 1409 TOPs were performed in the third trimester, vs. 305/956 in the historical series. There were 33 (16.1 %) diagnoses missed at the screening before the third trimester, 55 (26.8 %) cases in which the anomaly was impossible to diagnose until the third trimester, 86 (42 %) cases in which fetal prognosis could not be established until the third trimester despite earlier diagnosis, 31 (15.1 %) TOPs postponed to allow more time for the women/couples to contemplate, versus respectively 113 (37 %), 55 (18 %), 122 (40 %), and 15 (5%) in the historical series. There was a significant drop in the rate of anomalies missed earlier. The increase in late TOP due to couples requiring additional time for contemplation might result from changes in counselling processes.

Identifiants

pubmed: 32203822
pii: S0301-2115(20)30116-0
doi: 10.1016/j.ejogrb.2020.03.008
pii:
doi:

Types de publication

Comparative Study Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

123-127

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest No conflict of interest.

Auteurs

Anne-Gael Cordier (AG)

Department of Obstetrics and Gynaecology and Reproductive Medicine, AP-HP, Antoine Béclère Hospital, Clamart, F92140, Univ Paris-Saclay, France. Electronic address: anne-gael.cordier@aphp.fr.

Thibault Thubert (T)

Department of Obstetrics and Gynaecology and Reproductive Medicine, AP-HP, Antoine Béclère Hospital, Clamart, F92140, Univ Paris-Saclay, France.

Chloé Dussaux (C)

Department of Obstetrics and Gynaecology and Reproductive Medicine, AP-HP, Antoine Béclère Hospital, Clamart, F92140, Univ Paris-Saclay, France.

Pietro Santulli (P)

Department of Obstetrics and Gynaecology and Reproductive Medicine, AP-HP, Cochin Port Royal, Paris, France.

Marc Dommergues (M)

Department of Obstetrics and Gynaecology, AP-HP, Pitié Salpétrière Hospital and Univ Paris 6, Paris, France.

Olivier Picone (O)

Department of Obstetrics and Gynaecology and Reproductive Medicine, AP-HP, Antoine Béclère Hospital, Clamart, F92140, Univ Paris-Saclay, France.

Alexandra Benachi (A)

Department of Obstetrics and Gynaecology and Reproductive Medicine, AP-HP, Antoine Béclère Hospital, Clamart, F92140, Univ Paris-Saclay, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH